Disopyramide Phosphate and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Disopyramide Phosphate and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: disopyramide
Brand name: Norpace, Norpace CR
Synonyms: Disopyramide
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Disopyramide Phosphate-Moxifloxacin
- Disopyramide Phosphate-Moxifloxacin (Systemic)
- Disopyramide Phosphate-Moxifloxacin Hydrochloride
- Disopyramide Phosphate-Moxifloxacin Injection
- Disopyramide Phosphate-Moxifloxacin Intravenous
- Disopyramide Phosphate-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Disopyramide Sustained-Release Capsules
- Moxetumomab pasudotox-tdfk Intravenous-DisperMox
- Moxetumomab pasudotox-tdfk Intravenous-Disposable Enema rectal
- Moxetumomab pasudotox-tdfk Intravenous-Disulfiram
- Moxetumomab pasudotox-tdfk Intravenous-Dithol Solution
- Moxetumomab pasudotox-tdfk Intravenous-Ditropan